SUBSTITUIERTE PYRAZOLE ALS PPAR-AGONISTEN

European patent · EP1685113 · Deleted

Register entry

Publication number
EP1685113
Application number
EP04818779
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Nov 15, 2004
Published
Aug 2, 2006
Granted
Jul 30, 2008
Deleted
Nov 30, 2008
Reason
Annual fee unpaid
IPC classes
C07D 231/14 (2006.01)
C07D 409/10 (2006.01)
C07D 405/10 (2006.01)
C07D 401/10 (2006.01)
C07D 231/12 (2006.01)
A61K 31/415 (2006.01)
A61P 3/00 (2006.01)
Priority
GB 0326747 17.11.2003
GB 0329462 19.12.2003
PCT application
PCT/EP2004/012965 15.11.2004
PCT publication
WO2005/049578 02.06.2005
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Jun 17, 2009

    Deleted, fee unpaid

    Published in Swissreg on 17.06.2009

  2. Jul 30, 2008

    Granted

    Published in Swissreg on 30.07.2008

Parties

Holder

SmithKline Beecham Corporation

SMITHKLINE BEECHAM CORPORATION

One Franklin Plaza P.O. Box 7929, Philadelphia, PA 19101, US

Inventor

Faucher, N. E., GlaxoSmithKline, Ctre de Recherche

F-91940 Les Ulis, FR

Martres, Paul GlaxoSmithKline Centre de Recherches

F-91940 Les Ulis, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.